Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TUMOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03385343
What this trial is testing

Staging of Superficial EAC Using VLE

Who this might be right for
Esophageal Cancer
Mayo Clinic 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07768943
What this trial is testing

GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma

Who this might be right for
Natural Killer/T-cell Lymphoma
Fudan University 620
Testing effectiveness (Phase 2)Study completedNCT00603915
What this trial is testing

Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Early research (Phase 1)Not Yet RecruitingNCT07716735
What this trial is testing

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Who this might be right for
Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)WithdrawnNCT04408898
What this trial is testing

SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Adaptimmune
Early research (Phase 1)Study completedNCT00335998
What this trial is testing

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Who this might be right for
Recurrent Cervical CancerRecurrent Ovarian Epithelial CancerRecurrent Vaginal Cancer+15 more
National Cancer Institute (NCI) 24
Not applicableEnded earlyNCT03723863
What this trial is testing

Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIIBreast Cancer Stage II+6 more
University of Washington 15
Early research (Phase 1)Study completedNCT02611063
What this trial is testing

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Stefanie Sarantopoulos, MD, PhD. 22
Very early researchStudy completedNCT03358563
What this trial is testing

Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Post-approval studies (Phase 4)Ended earlyNCT06077487
What this trial is testing

Ketamine-assisted Therapy for Advanced GI Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPain, AcuteGastrointestinal Cancers+1 more
Brian Anderson, MD 1
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Not applicableUnknownNCT03501121
What this trial is testing

Extended Follow up of the TARGIT-A Trial

Who this might be right for
Breast Neoplasm Female
University College, London 714
Not applicableUnknownNCT04644406
What this trial is testing

PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study

Who this might be right for
HER-2 Positive Breast Cancer
Hospices Civils de Lyon 200
Large-scale testing (Phase 3)Looking for participantsNCT06296706
What this trial is testing

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 630
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Post-approval studies (Phase 4)Study completedNCT00488904
What this trial is testing

Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery

Who this might be right for
Colorectal Cancer
Aalborg University Hospital 148
Not applicableLooking for participantsNCT06709404
What this trial is testing

Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Wake Forest University Health Sciences 50
Testing effectiveness (Phase 2)Study completedNCT01138904
What this trial is testing

FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Cancer
Dong-A University Hospital 80
Not applicableStudy completedNCT02823184
What this trial is testing

Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
University Hospital, Bordeaux 148
Next Page